Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Obesity Reports

28-02-2024 | Obesity | REVIEW

Weight Gain in Midlife Women

Authors: Maria D. Hurtado, Mariam Saadedine, Ekta Kapoor, Chrisandra L. Shufelt, Stephanie S. Faubion

Published in: Current Obesity Reports

Login to get access

Abstract

Purpose of Review

To summarize the evidence and clinical implications of weight and body composition changes during midlife in women and provide an overview of weight gain prevention and management in this population.

Recent Findings

Aging-related changes such as decreased energy expenditure and physical activity are important culprits for weight gain in midlife women. The hormonal changes of menopause also influence body adiposity distribution and increase central adiposity. These body changes can have health consequences including the development of cardiometabolic diseases, osteoarthritis, cancer, worsening in cognition, mental health, and menopause symptoms.

Summary

Midlife women experience changes related to aging, menopause, and lifestyle which favor weight gain. Clinical practice should focus on early counseling and anticipatory guidance on the importance of dietary changes and physical activity to attenuate this phenomenon. Future research should focus on the longitudinal relationship between weight trends in midlife and health consequences and mortality.
Literature
1.
Sternfeld B, et al. Physical activity and changes in weight and waist circumference in midlife women: findings from the Study of Women’s Health Across the Nation. Am J Epidemiol. 2004;160(9):912–22.PubMedCrossRef
2.
Lewis TT, et al. Race, education, and weight change in a biracial sample of women at midlife. Arch Intern Med. 2005;165(5):545–51.PubMedCrossRef
3.
Field AE, et al. Dietary fat and weight gain among women in the Nurses’ Health Study. Obesity (Silver Spring). 2007;15(4):967–76.PubMedCrossRef
4.
5.
Pimenta F, et al. Predictors of weight variation and weight gain in peri- and post-menopausal women. J Health Psychol. 2014;19(8):993–1002.PubMedCrossRef
6.
Jung SY, et al. Risk profiles for weight gain among postmenopausal women: a classification and regression tree analysis approach. PLoS ONE. 2015;10(3): e0121430.PubMedPubMedCentralCrossRef
7.
Hutfless S, et al. AHRQ comparative effectiveness reviews, in Strategies to prevent weight gain among adults. 2013. Agency for Healthcare Research and Quality (US): Rockville (MD).
8.
9.
10.
Hales CM, et al. Prevalence of obesity and severe obesity among adults: United States, 2017–2018. NCHS Data Brief. 2020;360:1–8.
11.
Greendale GA, et al. Changes in body composition and weight during the menopause transition. JCI Insight. 2019;4(5):e124865.
12.
Ambikairajah A, et al. Fat mass changes during menopause: a metaanalysis. Am J Obstet Gynecol. 2019;221(5):393-409.e50.PubMedCrossRef
13.
Genazzani AR, Gambacciani M. Effect of climacteric transition and hormone replacement therapy on body weight and body fat distribution. Gynecol Endocrinol. 2006;22(3):145–50.PubMedCrossRef
14.
Kyle UG, et al. Fat-free and fat mass percentiles in 5225 healthy subjects aged 15 to 98 years. Nutrition. 2001;17(7–8):534–41.PubMedCrossRef
15.
Dmitruk A, et al. Body composition and fatty tissue distribution in women with various menstrual status. Rocz Panstw Zakl Hig. 2018;69(1):95–101.PubMed
16.
Sipilä S, et al. Muscle and bone mass in middle-aged women: role of menopausal status and physical activity. J Cachexia Sarcopenia Muscle. 2020;11(3):698–709.PubMedPubMedCentralCrossRef
17.
18.
19.
Heydenreich J, et al. Total energy expenditure, energy intake, and body composition in endurance athletes across the training season: a systematic review. Sports Med Open. 2017;3(1):8.PubMedPubMedCentralCrossRef
20.
21.
Basal metabolism in health and disease. Arch Intern Med. 1924;34(6):890–890.
22.
23.
24.
Geraci A, et al. Sarcopenia and menopause: the role of estradiol. Front Endocrinol (Lausanne). 2021;12: 682012.PubMedCrossRef
25.
Kitajima Y, Ono Y. Estrogens maintain skeletal muscle and satellite cell functions. J Endocrinol. 2016;229(3):267–75.PubMedCrossRef
26.
Davison SL, et al. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab. 2005;90(7):3847–53.PubMedCrossRef
27.
Burger HG, et al. A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition. J Clin Endocrinol Metab. 2000;85(8):2832–8.PubMed
28.
van Geel TA, et al. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle mass, muscle strength and bone mineral density in postmenopausal women: a cross-sectional study. Eur J Endocrinol. 2009;160(4):681–7.PubMedCrossRef
29.
Yuki A, et al. Low free testosterone is associated with loss of appendicular muscle mass in Japanese community-dwelling women. Geriatr Gerontol Int. 2015;15(3):326–33.PubMedCrossRef
30.
31.
32.
Wang D, et al. Healthy lifestyle during the midlife is prospectively associated with less subclinical carotid atherosclerosis: the Study of Women’s Health Across the Nation. J Am Heart Assoc. 2018;7(23): e010405.PubMedPubMedCentralCrossRef
33.
Pettee Gabriel K, et al. Physical activity trajectories during midlife and subsequent risk of physical functioning decline in late mid-life: the Study of Women’s Health Across the Nation (SWAN). Prev Med. 2017;105:287–94.PubMedCrossRef
34.
Duval K, et al. Effects of the menopausal transition on dietary intake and appetite: a MONET Group Study. Eur J Clin Nutr. 2014;68(2):271–6.PubMedCrossRef
35.
Macdonald HM, et al. Longitudinal changes in weight in perimenopausal and early postmenopausal women: effects of dietary energy intake, energy expenditure, dietary calcium intake and hormone replacement therapy. Int J Obes Relat Metab Disord. 2003;27(6):669–76.PubMedCrossRef
36.
Gibson CJ, et al. Association between vasomotor symptom frequency and weight gain in the Study of Women’s Health Across the Nation. Menopause. 2023;30(7):709–16.PubMedPubMedCentralCrossRef
37.
Gibson C, Matthews K, Thurston R. Daily physical activity and hot flashes in the Study of Women’s Health Across the Nation (SWAN) Flashes Study. Fertil Steril. 2014;101(4):1110–6.PubMedPubMedCentralCrossRef
38.
Gold EB, et al. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: Study of Women’s Health Across the Nation. Am J Public Health. 2006;96(7):1226–35.PubMedPubMedCentralCrossRef
39.
Thurston RC, et al. Abdominal adiposity and hot flashes among midlife women. Menopause. 2008;15(3):429–34.
40.
Saccomani S, et al. Does obesity increase the risk of hot flashes among midlife women?: a population-based study. Menopause. 2017;24(9):1065–70.PubMedCrossRef
41.
42.
Romani WA, Gallicchio L, Flaws JA. The association between physical activity and hot flash severity, frequency, and duration in mid-life women. Am J Hum Biol. 2009;21(1):127–9.PubMedPubMedCentralCrossRef
43.
44.
Khoudary SRE, et al. Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American Heart Association. Circulation. 2020;142(25):e506–32.PubMedCrossRef
45.
46.
Tsao CW, et al. Heart disease and stroke statistics—2023 update: a report from the American Heart Association. Circulation. 2023;147(8):e93–621.PubMedCrossRef
47.
Li W, et al. Association between age at onset of overweight and risk of hypertension across adulthood. Heart. 2022;108(9):683–8.PubMedCrossRef
48.
49.
Field AE, et al. Weight cycling, weight gain, and risk of hypertension in women. Am J Epidemiol. 1999;150(6):573–9.PubMedCrossRef
50.
Matthews KA, et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? J Am Coll Cardiol. 2009;54(25):2366–73.PubMedPubMedCentralCrossRef
51.
Wong VW, et al. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography. Gut. 2012;61(3):409–15.PubMedCrossRef
52.
Wang Z, et al. Sex-specific prevalence of fatty liver disease and associated metabolic factors in Wuhan, south central China. Eur J Gastroenterol Hepatol. 2014;26(9):1015–21.PubMedCrossRef
53.
Kojima S, et al. Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background. J Gastroenterol. 2003;38(10):954–61.PubMedCrossRef
54.
Wang Z, et al. Prevalence of nonalcoholic fatty liver disease and its metabolic risk factors in women of different ages and body mass index. Menopause. 2015;22(6):667–73.PubMedCrossRef
55.
DiStefano JK. NAFLD and NASH in postmenopausal women: implications for diagnosis and treatment. Endocrinology. 2020;161(10):bqaa134.
56.
Cotter TG, Rinella M. Nonalcoholic fatty liver disease 2020: the state of the disease. Gastroenterology. 2020;158(7):1851–64.PubMedCrossRef
57.
Noureddin M, et al. NASH leading cause of liver transplant in women: updated analysis of indications for liver transplant and ethnic and gender variances. Am J Gastroenterol. 2018;113(11):1649–59.PubMedPubMedCentralCrossRef
58.
Janssen I, et al. Testosterone and visceral fat in midlife women: the Study of Women’s Health Across the Nation (SWAN) fat patterning study. Obesity (Silver Spring). 2010;18(3):604–10.PubMedCrossRef
59.
Zhao D, et al. Abdominal obesity, chronic inflammation and the risk of non-alcoholic fatty liver disease. Ann Hepatol. 2023;28(4):100726.
60.
Gregg EW, et al. Trends in lifetime risk and years of life lost due to diabetes in the USA, 1985–2011: a modelling study. Lancet Diabetes Endocrinol. 2014;2(11):867–74.PubMedCrossRef
61.
Fang L, et al. Prevalence of diabetes in the USA from the perspective of demographic characteristics, physical indicators and living habits based on NHANES 2009–2018. Front Endocrinol (Lausanne). 2023;14:1088882.PubMedCrossRef
62.
Karvonen-Gutierrez CA, et al. Low grip strength predicts incident diabetes among mid-life women: the Michigan Study of Women’s Health Across the Nation. Age Ageing. 2018;47(5):685–91.PubMedPubMedCentralCrossRef
63.
Wang M, et al. Gender heterogeneity in dyslipidemia prevalence, trends with age and associated factors in middle age rural Chinese. Lipids Health Dis. 2020;19(1):135.PubMedPubMedCentralCrossRef
64.
NHANES. QuickStats: prevalence of high total cholesterol among adults aged ≥20 years, by age group and sex — National Health and Nutrition Examination Survey, 2015–2018. , Editor. MMWR Morb Mortal Wkly Rep. 2020;69:690.CrossRef
65.
de Kat AC, et al. Unraveling the associations of age and menopause with cardiovascular risk factors in a large population-based study. BMC Med. 2017;15(1):2.PubMedPubMedCentralCrossRef
66.
Badon SE, et al. Dual trajectories of physical activity and blood lipids in midlife women: the Study of Women’s Health Across the Nation. Maturitas. 2021;146:49–56.PubMedPubMedCentralCrossRef
67.
Thurston RC, et al. Menopause versus chronologic aging: their roles in women’s health. Menopause. 2018;25(8):849–54.PubMedCrossRef
68.
Kannel WB, et al. Menopause and risk of cardiovascular disease. Ann Intern Med. 1976;85(4):447–52.PubMedCrossRef
69.
Dam V, et al. Association of menopausal characteristics and risk of coronary heart disease: a pan-European case–cohort analysis. Int J Epidemiol. 2019;48(4):1275–85.PubMedPubMedCentralCrossRef
70.
71.
Sun Y, et al. Association of normal-weight central obesity with all-cause and cause-specific mortality among postmenopausal women. JAMA Netw Open. 2019;2(7):e197337–e197337.PubMedPubMedCentralCrossRef
72.
Hamer M, et al. Normal-weight central obesity and risk for mortality. Ann Intern Med. 2017;166(12):917–8.PubMedCrossRef
73.
Khan ZA, et al. Serial studies in subclinical atherosclerosis during menopausal transition (from the Study of Women’s Health Across the Nation). Am J Cardiol. 2018;122(7):1161–8.PubMedPubMedCentralCrossRef
74.
El Khoudary SR, et al. Postmenopausal women with greater paracardial fat have more coronary artery calcification than premenopausal women: the Study of Women’s Health Across the Nation (SWAN) Cardiovascular Fat Ancillary Study. J Am Heart Assoc. 2017;6(2):e004545.
75.
Arnold M, et al. Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncol. 2015;16(1):36–46.PubMedCrossRef
76.
77.
Ahn J, et al. Adiposity, adult weight change, and postmenopausal breast cancer risk. Arch Intern Med. 2007;167(19):2091–102.PubMedCrossRef
78.
Keum N, et al. Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies. JNCI: J Natl Cancer Inst. 2015;107(2):djv088.
79.
Schlesinger S, et al. Body weight gain and risk of colorectal cancer: a systematic review and meta-analysis of observational studies. Obes Rev. 2015;16(7):607–19.PubMedCrossRef
80.
Kothari C, Diorio C, Durocher F. The importance of breast adipose tissue in breast cancer. Int J Mol Sci. 2020;21(16):5760.
81.
Munsell MF, et al. Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status. Epidemiol Rev. 2014;36(1):114–36.PubMedPubMedCentralCrossRef
82.
de Araujo Dantas AB, et al. Worldwide prevalence and associated risk factors of obstructive sleep apnea: a meta-analysis and meta-regression. Sleep Breath. 2023;27(6):2083–109.
83.
Senaratna CV, et al. Prevalence of obstructive sleep apnea in the general population: a systematic review. Sleep Med Rev. 2017;34:70–81.PubMedCrossRef
84.
Franklin KA, et al. Sleep apnoea is a common occurrence in females. Eur Respir J. 2013;41(3):610–5.PubMedCrossRef
85.
Lawrence RC, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II Arthritis Rheum. 2008;58(1):26–35.PubMedCrossRef
86.
Lange-Maia BS, et al. Factors influencing longitudinal stair climb performance from midlife to early late life: the Study of Women’s Health Across the Nation Chicago and Michigan sites. J Nutr Health Aging. 2019;23(9):821–8.PubMedPubMedCentralCrossRef
87.
Szoeke CEI, et al. Factors affecting the prevalence of osteoarthritis in healthy middle-aged women: data from the longitudinal Melbourne Women’s Midlife Health Project. Bone. 2006;39(5):1149–55.PubMedCrossRef
88.
Lange-Maia BS, et al. Contribution of common chronic conditions to midlife physical function decline: the Study of Women’s Health Across the Nation. Womens Midlife Health. 2020;6:6.PubMedPubMedCentralCrossRef
89.
Felson DT. The epidemiology of knee osteoarthritis: results from the Framingham Osteoarthritis Study. Semin Arthritis Rheum. 1990;20(3 Suppl 1):42–50.PubMedCrossRef
90.
Reyes C, et al. Association between overweight and obesity and risk of clinically diagnosed knee, hip, and hand osteoarthritis: a population-based cohort study. Arthritis Rheumatol. 2016;68(8):1869–75.PubMedPubMedCentralCrossRef
91.
Issa RI, Griffin TM. Pathobiology of obesity and osteoarthritis: integrating biomechanics and inflammation. Pathobiol Aging Age Relat Dis. 2012;2:17470.
92.
Dahl A, et al. Being overweight in midlife is associated with lower cognitive ability and steeper cognitive decline in late life. J Gerontol A Biol Sci Med Sci. 2010;65(1):57–62.PubMedCrossRef
93.
Dahl AK, et al. Body mass index across midlife and cognitive change in late life. Int J Obes (Lond). 2013;37(2):296–302.PubMedCrossRef
94.
Pal L, et al. Cardiometabolic measures and cognition in early menopause - analysis of baseline data from a randomized controlled trial. Maturitas. 2022;162:58–65.PubMedPubMedCentralCrossRef
95.
96.
Darling CA, Coccia C, Senatore N. Women in midlife: stress, health and life satisfaction. Stress Health. 2012;28(1):31–40.PubMedCrossRef
97.
von Hippel C, et al. Sexual function among women in midlife: findings from the Nurses’ Health Study II. Womens Health Issues. 2019;29(4):291–8.CrossRef
98.
Steffen KJ, et al. Sexual functioning of men and women with severe obesity before bariatric surgery. Surg Obes Relat Dis. 2017;13(2):334–43.PubMedCrossRef
99.
Erbil N. The relationships between sexual function, body image, and body mass index among women. Sex Disabil. 2013;31(1):63–70.CrossRef
100.
Nackers LM, et al. Associations between body mass index and sexual functioning in midlife women: the Study of Women’s Health Across the Nation. Menopause. 2015;22(11):1175–81.PubMedPubMedCentralCrossRef
101.
Wing RR, et al. Effect of intensive lifestyle intervention on sexual dysfunction in women with type 2 diabetes: results from an ancillary Look AHEAD study. Diabetes Care. 2013;36(10):2937–44.ADSPubMedPubMedCentralCrossRef
102.
Halseth A, et al. Quality of life, binge eating and sexual function in participants treated for obesity with sustained release naltrexone/bupropion. Obes Sci Pract. 2018;4(2):141–52.PubMedPubMedCentralCrossRef
103.
Sarwer DB, et al. 4-Year changes in sex hormones, sexual functioning, and psychosocial status in women who underwent bariatric surgery. Obes Surg. 2018;28(4):892–9.PubMedPubMedCentralCrossRef
104.
Gold EB, et al. Longitudinal analysis of changes in weight and waist circumference in relation to incident vasomotor symptoms: the Study of Women’s Health Across the Nation (SWAN). Menopause. 2017;24(1):9–26.PubMedPubMedCentralCrossRef
105.
106.
Alexander C, et al. Serum leptin levels, hormone levels, and hot flashes in midlife women. Fertil Steril. 2010;94(3):1037–43.PubMedCrossRef
107.
Krychman M, et al. The Women’s EMPOWER Survey: women’s knowledge and awareness of treatment options for vulvar and vaginal atrophy remains inadequate. J Sex Med. 2017;14(3):425–33.PubMedCrossRef
108.
Pastore LM, et al. Self-reported urogenital symptoms in postmenopausal women: Women’s Health Initiative. Maturitas. 2004;49(4):292–303.PubMedCrossRef
109.
Curry SJ, et al. Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US Preventive Services Task Force recommendation statement. JAMA. 2018;320(11):1163–71.PubMedCrossRef
110.
• Cantor AG, et al. Preventing obesity in midlife women a systematic review for the Women’s Preventive Services Initiative. Ann Intern Med. 2022;175(9):1275–84. Counseling to prevent on results in less weight gain with relatively no harms.PubMedCrossRef
111.
Chelmow D, et al. Preventing obesity in midlife women: a recommendation from the Women’s Preventive Services Initiative. Ann Intern Med. 2022;175(9):1305–9.PubMedCrossRef
112.
Ranjan P, et al. Evidence and consensus-based clinical practice guidelines for management of overweight and obesity in midlife women: an AIIMS-DST initiative. J Family Med Prim Care. 2022;11(12):7549–601.PubMedCrossRef
113.
114.
Simkin-Silverman LR, et al. Lifestyle intervention can prevent weight gain during menopause: results from a 5-year randomized clinical trial. Ann Behav Med. 2003;26(3):212–20.PubMedCrossRef
115.
Howard BV, et al. Low-fat dietary pattern and weight change over 7 years: the Women’s Health Initiative Dietary Modification Trial. JAMA. 2006;295(1):39–49.MathSciNetPubMedCrossRef
116.
117.
Williams LT, et al. Can a relatively low-intensity intervention by health professionals prevent weight gain in mid-age women? 12-Month outcomes of the 40-Something randomised controlled trial. Nutr Diabetes. 2014;4(5): e116.PubMedPubMedCentralCrossRef
118.
Lawton BA, et al. Exercise on prescription for women aged 40–74 recruited through primary care: two year randomised controlled trial. BMJ. 2008;337: a2509.PubMedPubMedCentralCrossRef
119.
120.
Khan SJ, et al. Vasomotor symptoms during menopause: a practical guide on current treatments and future perspectives. Int J Womens Health. 2023;15:273–87.PubMedPubMedCentralCrossRef
121.
Ayers B, et al. Effectiveness of group and self-help cognitive behavior therapy in reducing problematic menopausal hot flushes and night sweats (MENOS 2): a randomized controlled trial. Menopause. 2012;19(7):749–59.PubMedCrossRef
122.
Elkins GR, et al. Clinical hypnosis in the treatment of postmenopausal hot flashes: a randomized controlled trial. Menopause. 2013;20(3):291–8.PubMedCrossRef
123.
The 2023 Nonhormone Therapy Position Statement of The North American Menopause Society. Menopause. 2023;30(6):573–90.CrossRef
124.
125.
Chen Z, et al. Postmenopausal hormone therapy and body composition—a substudy of the estrogen plus progestin trial of the Women’s Health Initiative. Am J Clin Nutr. 2005;82(3):651–6.ADSPubMedCrossRef
126.
Papadakis GE, et al. Menopausal hormone therapy is associated with reduced total and visceral adiposity: the OsteoLaus cohort. J Clin Endocrinol Metab. 2018;103(5):1948–57.PubMedCrossRef
127.
Javed AA, et al. Association between hormone therapy and muscle mass in postmenopausal women: a systematic review and meta-analysis. JAMA Netw Open. 2019;2(8):e1910154–e1910154.ADSPubMedPubMedCentralCrossRef
128.
Weidlinger S, et al. Impact of estrogens on resting energy expenditure: a systematic review. Obes Rev. 2023;24(10): e13605.PubMedCrossRef
129.
Salpeter SR, et al. Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes Obes Metab. 2006;8(5):538–54.PubMedCrossRef
130.
131.
Arciero PJ, et al. Increased protein intake and meal frequency reduces abdominal fat during energy balance and energy deficit. Obesity. 2013;21(7):1357–66.PubMedCrossRef
132.
Bellicha A, et al. Effect of exercise training on weight loss, body composition changes, and weight maintenance in adults with overweight or obesity: an overview of 12 systematic reviews and 149 studies. Obes Rev. 2021;22(Suppl 4):e13256.CrossRef
133.
Yeh ML, et al. Exercises improve body composition, cardiovascular risk factors and bone mineral density for menopausal women: a systematic review and meta-analysis of randomized controlled trials. Appl Nurs Res. 2018;40:90–8.PubMedCrossRef
134.
Pimenta F, et al. Brief cognitive-behavioral therapy for weight loss in midlife women: a controlled study with follow-up. Int J Womens Health. 2012;4:559–67.PubMedPubMedCentralCrossRef
135.
Bray GA, Ryan DH. Evidence-based weight loss interventions: individualized treatment options to maximize patient outcomes. Diabetes Obes Metab. 2021;23(Suppl 1):50–62.PubMedCrossRef
Metadata
Title
Weight Gain in Midlife Women
Authors
Maria D. Hurtado
Mariam Saadedine
Ekta Kapoor
Chrisandra L. Shufelt
Stephanie S. Faubion
Publication date
28-02-2024
Publisher
Springer US
Published in
Current Obesity Reports
Electronic ISSN: 2162-4968
DOI
https://doi.org/10.1007/s13679-024-00555-2
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits